Skip to content

NAMSW

NewAmsterdam Pharma Co. NV

NASDAQ · Healthcare · Biotechnology · NL

$9.06
+0.67%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
23.54x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
1.64x
Price / sales
145.55x
Price / cash flow
-7.22x

Enterprise value

Enterprise value
$402.7M
EV / sales
56.55x
EV / EBITDA
-1.58x
EV / EBIT
-1.65x
Market cap
$1.0B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026